Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.
2.

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Lister PD, Wolter DJ, Hanson ND.

Clin Microbiol Rev. 2009 Oct;22(4):582-610. doi: 10.1128/CMR.00040-09. Review.

4.

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.

Wolter DJ, Black JA, Lister PD, Hanson ND.

J Antimicrob Chemother. 2009 Aug;64(2):294-300. doi: 10.1093/jac/dkp185. Epub 2009 May 25.

5.

A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.

Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S.

J Antimicrob Chemother. 2007 Jul;60(1):132-5. Epub 2007 May 4.

6.

Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.

Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.

Diagn Microbiol Infect Dis. 2004 Sep;50(1):43-50.

PMID:
15380277
7.
8.

Pseudomonas aeruginosa - a phenomenon of bacterial resistance.

Strateva T, Yordanov D.

J Med Microbiol. 2009 Sep;58(Pt 9):1133-48. doi: 10.1099/jmm.0.009142-0. Epub 2009 Jun 15. Review.

PMID:
19528173
9.

Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.

Obritsch MD, Fish DN, MacLaren R, Jung R.

Pharmacotherapy. 2005 Oct;25(10):1353-64. Review.

PMID:
16185180
10.

The intrinsic resistome of Pseudomonas aeruginosa to β-lactams.

Alvarez-Ortega C, Wiegand I, Olivares J, Hancock RE, Martínez JL.

Virulence. 2011 Mar-Apr;2(2):144-6. Epub 2011 Mar 1. Review.

PMID:
21304266
11.

Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital.

Vettoretti L, Floret N, Hocquet D, Dehecq B, Plésiat P, Talon D, Bertrand X.

Eur J Clin Microbiol Infect Dis. 2009 Oct;28(10):1217-22. doi: 10.1007/s10096-009-0767-8. Epub 2009 Jun 7.

PMID:
19504273
12.

Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.

Lister PD, Wolter DJ, Wickman PA, Reisbig MD.

J Antimicrob Chemother. 2006 May;57(5):999-1003. Epub 2006 Mar 2.

13.
14.

[Pseudomonas aeruginosa--a significant hospital pathogen and resistance to carbapenem].

Kucisec-Tepes N.

Acta Med Croatica. 2004;58(4):313-21. Review. Croatian.

PMID:
15700688
15.
17.

Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.

Bonomo RA, Szabo D.

Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S49-56. Review.

18.

Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.

Rossolini GM, Mantengoli E.

Clin Microbiol Infect. 2005 Jul;11 Suppl 4:17-32. Review.

19.

Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: first report in Algeria.

Drissi M, Ahmed ZB, Dehecq B, Bakour R, Plésiat P, Hocquet D.

Med Mal Infect. 2008 Apr;38(4):187-91. doi: 10.1016/j.medmal.2008.01.009. Epub 2008 Apr 18.

PMID:
18395380
20.

Characterization of poxB, a chromosomal-encoded Pseudomonas aeruginosa oxacillinase.

Kong KF, Jayawardena SR, Del Puerto A, Wiehlmann L, Laabs U, Tümmler B, Mathee K.

Gene. 2005 Sep 26;358:82-92.

PMID:
16120476
Items per page

Supplemental Content

Write to the Help Desk